Economics and the Drug Pricing Debate
Through presentation and moderated panel discussion, this plenary will tackle the economics and political issues of the current drug pricing debate. Panelists will discuss the impact of recent trends in drug pricing, volume-based rebate contracting, and consolidation among payers, PBMs and pharmacies on total drug spending, patient out-of-pocket spending, market competition, and access. Included in the debate will be economic evidence gaps. Panelists will also discuss the most promising policy approaches to better balance incentivizing and rewarding innovation with better value and access for patients.